Sbi Securities Co., Ltd. I Mab Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in I Mab stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 305 shares of IMAB stock, worth $1,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
305
Previous 905
66.3%
Holding current value
$1,174
Previous $746,000
1.07%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMAB
# of Institutions
39Shares Held
14.5MCall Options Held
20KPut Options Held
13.3K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$23 Million0.15% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$16 Million3.04% of portfolio
-
Candriam S.C.A.1.13MShares$4.36 Million0.02% of portfolio
-
Sg Americas Securities, LLC876KShares$3.37 Million0.01% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny363KShares$1.4 Million0.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $320M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...